Hong Kong and Macau suspended the use of Pfizer-BioNTech’s COVID-19 vaccine on Wednesday (Mar 24 2021) after being informed of a packaging problem affecting one batch of vials, while stressing they did not believe there was a safety risk.
“For the sake of precaution, the current vaccination must be suspended during the period of investigation,” Hong Kong’s government said in a statement.
Both Chinese cities said their decision came after they were contacted about the issue by Fosun, the Chinese pharmaceutical company that is distributing the Pfizer-BioNTech vaccine in China.
